Projects

Projects per year 2010 2019 2021 2022 2024 2029

• 17 Finished
• 18 Active

Projects per year

Search results

• Finished

  IOFACC10B: IOF Accelerator: “FLT imaging using Nanobodies: effective tool for life sciences and medical applications (NLITE)

  Lahoutte, T., Hernot, S., Kuijk, M. & Ingelberts, H.

  1/10/22 → 2/03/24

  Project: Applied

  • Single-Domain Antibodies 100%
  • Colorectal Neoplasms 32%
  • Computer-Assisted Surgery 18%
  • Biological Science Disciplines 16%
  • Costs and Cost Analysis 16%

• BRGCON29: Connect 2022: CODAFLIGHT: Colouring the dark in Fluorescence Light

  Kuijk, M., Ingelberts, H. & Hernot, S.

  16/02/22 → 4/05/22

  Project: Policy Based

  • Fluorescence 100%
  • Fluorescence imaging 70%
  • fluorescence 65%
  • Coloring 51%
  • Optical systems 49%

• AIIFUND111: Validation of fluorescent anti-uPAR nanobody in an orthotopic xenograft tumor model

  Hernot, S. & Mateusiak, L.

  7/02/22 → 31/08/23

  Project: Fundamental

  • Single-Domain Antibodies 100%
  • Heterografts 60%
  • neoplasms 51%
  • image analysis 37%
  • quality of life 26%

• FWOAL1026: ERA-NET RUS.PLUS - JTC 2019: NANOtechnological TOolkit for multiplexed 3D detection and monitoring of BIOmarker status in breast cancer biopsies

  Hernot, S.

  1/07/21 → 30/06/24

  Project: Fundamental

  • Biopsy 100%
  • Biomarkers 85%
  • Tumors 39%
  • Nanoprobes 27%
  • Monitoring 25%

• AIIFUND71: Visiting Researcher Agreement - Pharmacokinetic analysis of anti-VEGF single domain antibodies at macro- and microscopic level

  Hernot, S., öktem, I. M. A. & Cobanoglu, N. E. K.

  15/05/21 → 9/11/21

  Project: Fundamental

  • Single-Domain Antibodies 100%
  • Organized Financing 79%
  • Vascular Endothelial Growth Factor A 58%
  • researchers 55%
  • Pharmacokinetics 50%

• FWOAL951: Unraveling kidney clearance mechanisms of nanobodies

  Hernot, S. & Bridoux, J.

  1/01/20 → 31/12/23

  Project: Fundamental

  • Single-Domain Antibodies 100%
  • Kidney 52%
  • Radiopharmaceutical 41%
  • Radiopharmaceuticals 40%
  • Molecular Weight 28%

• FWOSB74: Intra-operative imaging in prostate and cervical cancer surgery using fluorescently-labelled nanobodies.

  Hernot, S., Devoogdt, N. & Declerck, N.

  1/11/19 → 31/10/23

  Project: Fundamental

  • Single-Domain Antibodies 100%
  • Computer-Assisted Surgery 61%
  • Label 58%
  • Fluorescence 52%
  • Clearance 36%

• ANI228: Intra-operative imaging in prostate and cervical cancer surgery using fluorescently-labelled nanobodies

  Hernot, S. & Declerck, N.

  1/10/19 → 31/10/19

  Project: Fundamental

  • Single-Domain Antibodies 100%
  • surgery 67%
  • Uterine Cervical Neoplasms 62%
  • Prostatic Neoplasms 53%
  • image analysis 47%

• FWOAL920: Image sensors enabling fluorescence-lifetime guided surgery

  Kuijk, M. & Hernot, S.

  1/01/19 → 31/12/22

  Project: Fundamental

  • Fluorescence 100%
  • Photonics 62%
  • Quantum efficiency 57%
  • Cameras 56%
  • samplers 53%

• HERC45: FWO Hercules MZW: Light sheet fluorescence microscopy in life sciences and medical research

  Sermon, K., Van De Velde, H., Goossens, E., Baeyens, L., Van Ginderachter, J., De Bundel, D., Hernot, S., De Kock, J., Vinken, M., Vanhaecke, T., Marcelino Rodrigues, R. & van Grunsven, L.

  1/05/18 → 30/04/22

  Project: Fundamental

  • biomedical research 100%
  • mice 97%
  • confocal microscopy 94%
  • sampling 89%
  • fluorescence microscopy 86%

• ANI183: Hybrid near-infrared fluorescence and nuclear imaging in ovarian cancer with uPAR-specific nanobodies for intra-operative navigation.

  Hernot, S. & Mateusiak, L.

  1/01/17 → 31/03/21

  Project: Fundamental

  • Computer-Assisted Surgery 100%
  • Single-Domain Antibodies 97%
  • Molecular Imaging 43%
  • Optical Imaging 41%
  • Fluorescence 33%

• OZR3015: Prijs Kankeronderzoek 2016: Afwerk-, overbruggingsbeurs tbv Pieterjan Debie

  Hernot, S. & Debie, P.

  1/01/17 → 1/01/18

  Project: Policy Based

  • Single-Domain Antibodies 100%
  • Theoretical Models 54%
  • Optical Imaging 27%
  • Neoplasms 21%
  • Fluorescence 20%

• EU514: PET Imaging in Drug Design and Development (PET3D)

  Caveliers, V., Xavier, C., Hernot, S., Devoogdt, N. & Bridoux, J.

  1/06/16 → 31/05/20

  Project: Fundamental

  • Contracts 100%
  • Positron-Emission Tomography 79%
  • Drug Development 71%
  • Drug Design 61%
  • Radiochemistry 18%

• ANI102: Image-guided surgery of breast cancer using near-infrared fluorescently-conjugated nanobodies

  Lahoutte, T. & Hernot, S.

  1/10/13 → 30/09/17

  Project: Fundamental

  • Surgery 100%
  • Infrared radiation 85%
  • Fluorescent Dye 51%
  • Chemistry 28%
  • Fluorescence 28%

• FWOAL664: Evaluation of mRNA-loaded micro bubbles for ultrasound-guided cancer vaccination

  Breckpot, K., Hernot, S., De Smedt, S. & Lentacker, S.

  1/01/13 → 31/12/16

  Project: Fundamental

  • trimix 100%
  • Immunotherapy 73%
  • Microbubbles 66%
  • Immunogenic Cell Death 66%
  • Messenger RNA 47%

• OZR2153: Nanobody-Loaded and -Coated Microbubbles: A Tool For Drug Delivery and Molecular Imaging

  Lahoutte, T. & Hernot, S.

  1/01/11 → 30/04/11

  Project: Fundamental

  • Drug 100%

• GOA74: Nanobody Translational Molecular Imaging

  Lahoutte, T., Caveliers, V., Devoogdt, N., Xavier, C., TCHOUATE GAINKAM Lea, O., D'Huyvetter, M., Hernot, S., Keyaerts, M., Vaneycken, I. & Van Hove, C.

  1/01/10 → 31/12/12

  Project: Fundamental

  • Single-Domain Antibodies 100%
  • ErbB Receptors 64%
  • translational medical research 52%
  • Single Photon Emission Computed Tomography Computed Tomography 44%
  • applied research 42%